Companies Dominating the Extracorporeal Membrane Oxygenation Machine Landscape
- Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Getinge AB
- LivaNova PLC
- Terumo Corporation
- Xenios AG
- Microport Scientific Corporation
- Eurosets S.r.l.
- Johnson & Johnson
- Abbott
- Fresenius Medical Care
The competitive landscape of the extracorporeal membrane oxygenation machine market is rapidly evolving as established key players, health giants, and new entrants are investing in advanced technologies. Key players in the market are focused on catering to the stringent regulatory norms and consumer demand. These key players are adopting several strategies such as mergers and acquisitions, joint ventures, partnerships, and novel product launches to enhance their product base and strengthen their market position. Here are some key players operating in the global market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of extracorporeal membrane oxygenation machine is evaluated at USD 544.73 million.
Asia Pacific industry is poised to dominate the majority revenue share of 36% by 2037, impelled by research and development in the pharmaceutical sector in the region.
The major players in the market include Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Xenios AG, Microport Scientific Corporation, Eurosets S.r.l., Johnson & Johnson, Abbott, Fresenius Medical Care.
Extracorporeal Membrane Oxygenation Machine Market size was valued at USD 527.02 million in 2024 and is set to exceed USD 899.72 million by 2037, expanding at over 4.2% CAGR during the forecast period, i.e., between 2025 and 2037.
